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OBJECTIVE: The aim of this placebo-controlled study was to evaluate the effects of pulsed and continuous
ultrasound treatments combined with splint therapy on patients with mild and moderate idiopathic carpal
tunnel syndrome.
METHODS: The study included 46 carpal tunnel syndrome patients who were randomly divided into 3 groups.
The first group (n= 15) received a 0 W/cm2 ultrasound treatment (placebo); the second group (n = 16) received
a 1.0 W/cm2 continuous ultrasound treatment and the third group (n =15) received a 1.0 W/cm2 1:4 pulsed
ultrasound treatment 5 days a week for a total of 15 sessions. All patients also wore night splints during
treatment period. Pre-treatment and post-treatment Visual Analogue Scale, Symptom Severity Scale and
Functional Status Scale scores, median nerve motor conduction velocity and distal latency and sensory
conduction velocities of the median nerve in the 2nd finger and palm were compared. Clinicaltrials.gov:
NCT02054247.
RESULTS: There were significant improvements in all groups in terms of the post-treatment Functional Status
Scale score (p,0.05 for all groups), Symptom Severity Scale score (first group: p,0.05, second group: p,0.01,
third group: p,0.001) and Visual Analogue Scale score (first and third groups: p,0.01, second group:
p,0.001). Sensory conduction velocities improved in the second and third groups (p,0.01). Distal latency in
the 2nd finger showed improvement only in the third group (p,0.01) and action potential latency in the palm
improved only in the second group (p,0.05).
CONCLUSION: The results of this study suggest that splinting therapy combined with placebo and pulsed or
continuous ultrasound have similar effects on clinical improvement. Patients treated with continuous and
pulsed ultrasound showed electrophysiological improvement; however, the results were not superior to those
of the placebo.
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& INTRODUCTION
Carpal tunnel syndrome (CTS) is an entrapment mono-
neuropathy that is commonly observed in clinical practice
and is caused by the compression of the median nerve at the
wrist (1). When the median nerve is compressed in the
tunnel, the patient develops the signs and symptoms of
CTS. The most common symptoms of CTS include pain,
paresthesia, numbness or tingling involving the fingers that
are innervated by the median nerve and a weakness of
thumb abduction. The symptoms are at their worst at night
and often wake the patient (2).
Both conservative and surgical treatments are used to
relieve the pressure on the median nerve (1). The choice
between conservative and surgical treatment is determined
by the severity of the symptoms and the patient’s physical
limitations (3).
Conservative treatment of CTS would seem to be
preferable as the initial treatment choice, particularly for
mild to moderate cases (1). However, the efficacy of
conservative treatment options for CTS is controversial (1).
Ultrasound (US) is a widely used and accepted adjunct
modality for the management of many musculoskeletal
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conditions (4). US converts electrical energy into an acoustic
waveform, which is then converted into heat as it passes
through tissues of varying resistance (5). Therapeutic US is
reported to reduce edema, relieve pain and accelerate tissue
repair (6-8). The exact mechanism of action of therapeutic
US remains to be elucidated, although it is used to
treat various musculoskeletal disorders. Analgesia that is
induced by therapeutic US may be the result of increased
capillary permeability and tissue metabolism, the enhance-
ment of fibrous tissue extensibility and the elevation of the
pain threshold by thermal mechanisms (6,9). Therapeutic
US can be applied as pulsed or continuous therapy.
Only a few studies have reported the benefits of
therapeutic US in CTS patients and there are conflicting
results on its efficacy in the treatment of CTS (1,10,11).
Recently, the effectiveness of pulsed and continuous US
therapy was compared with a placebo and the authors
reported satisfactory effects in patients with mild to
moderate CTS (10,12,13).
Splinting is the most popular method among the
conservative treatments that are available for CTS (13-15).
Immobilization of the wrist in a neutral position with a
splint maximizes the carpal tunnel volume and minimizes
the pressure on the median nerve (1).
The aim of this study was to evaluate the effects of pulsed
and continuous US treatments in combination with splint
therapy on patients with mild and moderate idiopathic CTS
compared to a placebo.
& METHODS
The study was carried out at the outpatient clinic of
the Eskisehir Osmangazi University Faculty of Medicine,
Department of Physical Medicine and Rehabilitation bet-
ween October 2011 and January 2013. A total of 36 female
patients with clinical and electrophysiological evidence of
mild or moderate idiopathic CTS (without thenar atrophy or
spontaneous activity as determined by the electrophysiolo-
gical examination of the abductor pollicis brevis (APB)
muscle) were included in the study. All of the patients had
unilateral CTS and were right-handed.
Patients were excluded if they had secondary entrapment
neuropathies, cervical radiculopathy or systemic diseases
that are associated with increased CTS risk in addition to
those who had undergone surgery for the syndrome, had
been treated with US or had a history of steroid injections
into the carpal tunnel and physical therapy within the last
3 months. Additionally, patients with either thenar atrophy
or spontaneous activity (fibrillation potentials and positive
sharp waves) as determined by an electrophysiological
examination of the APB muscle were excluded from the
study.
Study design
This study was designed as a prospective, randomized,
placebo-controlled, double-blind study. All of the patients
were assessed by the same physiatrist before beginning
treatment and at the end of the three weeks of treatment.
Before initiation and after the three weeks, all of the patients
were assessed by the same physiatrist. Neither the investi-
gator nor the patients were informed of the treatment
assignments. The study was conducted in full compliance
with the amended Declaration of Helsinki after obtaining
approval from the institutional review board of Eskisehir
Osmangazi University (date/n :˚ 18-05-2012/127). Following
baseline assessments, the patients who fulfilled the inclu-
sion criteria and were included in the study were randomly
assigned to one of three groups using a secure system of
opaque closed envelopes that were numbered from 1 to 3.
Forty-six patients were randomly assigned to one of
the three groups: group 1 (n = 15) received splinting and
continuous US therapy; group 2 (n = 16) received splinting
and pulsed US therapy and group 3 (n = 15) received
splinting and a ‘sham’ (placebo) US therapy.
Treatment protocol
Custom-made neutral volar splints were given to all of
the patients that were included in the study. They were
instructed to wear the splints at night and during the day
for a total of three weeks.
Continuous, pulsed and sham US therapies were per-
formed on all of the patients by the same physiotherapist.
In group 1 (continuous US group), US treatments were
administered to the carpal tunnel area at a frequency of 1
with an intensity of 1 W/cm2 and a transducer of 5 cm2 in
size (Sonopuls 434; Enraf Nonius, Delft, The Netherlands),
using aquasonic gel that did not contain any pharmacolo-
gically active substances. The apparatus was initially
standardized and the output was controlled by a simple
underwater radiation balance.
In group 2 (pulsed US group), the same US equipment
was set at a frequency of 1 MHz with an intensity of 1 W/
cm2 and a pulsed mode duty cycle of 1:4. The duration of the
applied US and the posture of the patient being treated were
the same as those that were described for the continuous US
group. The patients in group 3 (placebo US group) received
a ‘sham’ US application wherein the US device that was
described above appeared to be working but did not deliver
any output. US treatment sessions were performed once a
day, five days a week, for a total of three weeks.
Evaluations
All of the patients were evaluated immediately before and
after the three-week treatment by a blinded investigator
with respect to the parameters that are described below.
Electrophysiological evaluations
Electrophysiological evaluations were performed at base-
line and at the end of the treatment. Using standard
techniques, all of the electrodiagnostic tests were performed
by the same physician using a Medelec Sapphire 4 ME
(Medelec, Old Woking, UK) electromyography apparatus.
The hands of each patient were warmed prior to testing by
seating them for 15 minutes in an examining room at a
temperature of 22-24 C˚. To evaluate the median nerve,
motor distal latency (DL), motor nerve conduction velocity
(NCV), sensory DL and palm-wrist sensory NCV measure-
ments were measured in all patients. Surface stimulation
and recording electrodes were used for the sensory and
NCV tests employing standard methodology (16). The
compound muscle action potentials of the abductor pollicis
brevis muscle that were induced by supramaximal electrical
stimulation on the median nerve at the wrist 8 cm from the
recording electrode were recorded. DL and NCV studies
were performed from the wrist to the APB muscle at a
distance of 8 cm. For the sensory nerve conduction studies,
the median sensory fibers were stimulated antidromically at
the midpalm and wrist at distances of 7 cm and 14 cm from
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the recording ring electrode that was looped around the
proximal interphalangeal joint of the third digit. The onset
latencies of the negative potentials were taken into
consideration. For sensory testing, the sweep-speed velocity
was set at 10 msec, whereas for motor testing, it was set at
30 msec; the duration of the stimulus was 0.1 msec in both
studies. The voltage was increased until the action poten-
tials reached maximal amplitude. The main electrophysio-
logical criteria for the diagnosis of CTS were the slowing of
sensory nerve conduction velocity of the median nerve in
the palm-wrist segment or an absence of sensory nerve
action potential of the median nerve that was accompanied
by prolonged terminal motor latency (17). In our electro-
physiology laboratory, if the median nerve DL was 3.9 msn
or above, the median nerve sensory latency was 3 msn or
above and the sensory nerve conduction velocity of the
median nerve in the palm-wrist segment was 35.2 m/sn or
below, the subjects were considered to have CTS.
Clinical assessment
A blinded physician who was unaware of the treatment
allocations performed the clinical assessments at baseline
and at the end of the treatments. Symptom Severity scores
(SSSs), Functional Status scores (FSSs) and a Visual Analog
Scale (VAS) were used for the clinical follow-up and
evaluation of the patients.
The severity of the pain was assessed using a VAS
consisting of 10-cm horizontal lines with anchor points of 0
(no pain) and 10 (maximum pain). The Symptom Severity
Scale has 11 items in relation to pain, including nocturnal
symptoms, numbness, tingling and weakness (18). The
Functional Status Scale encompasses 8 items (difficulty in
writing, buttoning clothes, opening jars, holding a book,
gripping a telephone handle, performing household chores,
carrying grocery bags, bathing and dressing). Each item
in these scales has five ordinal response categories,
ranging from 1 (no symptoms or no difficulty) to 5 (severe
symptoms).
Statistical analyses
Statistical analyses were performed using SPSS 18.0 for
Windows. The normality of the distribution of the data was
confirmed by the Kolmogorov-Smirnov test. The results
were analyzed by a one-way ANOVA with post-hoc Tukey
HSD tests and t-tests. The results were reported as the
mean¡SD. Power calculations were evaluated using a one-
way ANOVA and the power of the study was 0.70 (70%).
The significance level was set at p,0.05.
& RESULTS
Table 1 shows the demographic characteristics of the
study groups. No significant differences were observed
between the groups. There were significant improvements
in all groups for all clinical parameters. There were no
significant differences between the groups (Table 2).
Table 3 shows a comparison of the electrophysiological
measurements that were obtained before and after the
treatments. The sensory conduction velocity of the median
nerve showed improvement in the second and third groups,
the sensory DL of the median nerve (digit II to palm)
improved only in the third group, and the sensory DL of the
median nerve (palm to wrist) improved only in the second
group. There were no significant differences between the
groups.
& DISCUSSION
CTS is one of the most common hand disorders. The
highest incidence is among middle-aged and elderly women
(19). Although several treatment modalities are routinely
used, there is no consensus regarding the best way to manage
CTS. The aim of this placebo-controlled study was to evaluate
Table 1 - Demographic characteristics of the patients.
Group 1 (n= 15)
Mean ¡ SD
Group 2 (n= 16)
Mean ¡ SD
Group 3 (n = 15)
Mean ¡ SD p-value
Age (years) 45.20¡2.98 43.31¡2.79 44.53¡2.38 0.883
Duration of symptoms (months) 13.67¡3.52 12.00¡3.29 11.87¡2.70 0.908










FSS Baseline 21.33¡7.37 24.00¡5.58 19.00¡0.85 0.019
Post-treatment 18.80¡7.34 19.31¡9.42 14.20¡4.52 0.125
p-value 0.036 0.041 0.003
SSS Baseline 26.60¡8.11 29.75¡7.71 25.93¡4.46 0.274
Post-treatment 23.06¡8.13 22.06¡8.73 19.66¡4.60 0.442
p-value 0.047 0.002 0.001
VAS Baseline 5.40¡2.32 5.56¡1.75 5.20¡1.26 0.859
Post-treatment 4.40¡2.32 2.68¡1.92 3.53¡1.95 0.083
p-value 0.006 0.000 0.003
FSS: Functional Status Scale.
SSS: Symptom Severity Scale.
VAS: Visual Analogue Scale.
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the effects of pulsed and continuous US treatments in
combination with splinting therapy on various clinical and
electrophysiological parameters in patients with CTS.
Splinting is the most popular method among the
conservative treatment modalities that are available for
CTS (14,15). The efficacy of wrist splinting therapy has
been variably demonstrated in several studies (15,20,21).
Premoselli et al. reported that splinting therapy improved
symptoms and electrophysiological parameters in CTS
patients (21).
In our study, a night rest splint was used by all of the
participants and clinical improvement was observed in all
of the groups. Placebo US can lead to symptom relief by
producing a local massage effect; however, this sympto-
matic improvement may be, in fact, related to the splinting
therapy, as has been observed in recent studies investi-
gating the beneficial effects of splinting therapy in CTS.
Electrophysiological improvement was found in the con-
tinuous and pulsed US groups but not in the placebo group.
US is used extensively in musculoskeletal disorders. A
few studies have found US therapy to be effective for CTS
(10,12,13). However, a consensus has yet to be reached
regarding the optimal therapeutic US parameters (intensity,
frequency of sound waves, duration, pulse, etc.) (1,10,13,22).
Therapeutic US can be applied in a pulsed or continuous
manner. Pulsed US has been recommended for acute
pain and inflammation, whereas continuous US has been
recommended for the treatment of restricted movement
(23). Pulsed US produces non-thermal effects and is used to
aid in the reduction of inflammation, whereas continuous
US generates thermal effects (6).
The aim of this study was to compare the effects of
pulsed and continuous US treatments on patients with CTS.
In the placebo-controlled study that was conducted by
Ebenbichler et al., the US method was similar to that which
was used in our study with the exception of the therapy
time (1 MHz, 1.0 W/cm2 in pulsed mode 1:4 for 15 min per
session). This group revealed the clinical and electrophy-
siological improvement of CTS symptoms (10). In another
study comparing the efficiency of US and laser therapy, US
(1 MHz, 1.0 W/cm2 in pulsed mode 1:4 for 15 min per
session) was found to be more effective than laser therapy
for CTS in terms of electrophysiological parameters (22).
US therapy in combination with splinting therapy was
compared with ketoprofen phonophoresis in a placebo-
controlled study and the electrophysiological and clinical
parameters were reported to improve in both groups
(24). Electrophysiological and clinical improvements were
observed in our study in the pulsed US group. These results
are in agreement with those from other studies, although
there are some methodological differences.
In the group that received continuous US therapy in
combination with splinting therapy, the treatment was
applied for 10 min per session to the carpal tunnel area at
a frequency of 1 and an intensity of 1 W/cm2. The efficacy
of continuous US in CTS has been previously evaluated in
only a few studies (12,25,26). A placebo-controlled study
reported clinical and electrophysiological improvement
using different doses of US therapy (1.5 W/cm2, 0.8 W/
cm2, 0 W/cm2). In addition, the NCV decreased slightly and
DL increased in the US group (13). In a placebo-controlled
study evaluating low-intensity (0.5 W/cm2) US, a signifi-
cant improvement in clinical variables was observed after
the treatment, although there were no differences in the
electrophysiological variables (12). In another placebo-
controlled study, clinical improvement was observed with
US therapy (1.5 W/cm2); however, no electrophysiological
improvement was found (25).
Because the US intensities that were used differ in all of
these studies, it is difficult to compare results. Furthermore,
there is no consensus in the literature regarding the effective
dose for US therapy. Similarly to our study, Dincer et al.
compared splinting therapy alone with continuous US
therapy (at an intensity of 1.0 W/cm2) combined with
splinting therapy in addition to laser therapy combined
with splinting therapy and found clinical and electrophy-
siological improvement in the combined therapy groups
(26).










Motor NCV Baseline 53.82¡4.10 56.15¡4.44 58.05¡6.43 0.086
Post-treatment 54.26¡4.29 55.68¡5.24 57.91¡5.44 0.146
p-value 0.705 0.766 0.943
SDL (digit II to palm) Baseline 3.50¡0.72 3.46¡0.68 3.45¡0.58 0.979
Post-treatment 3.49¡0.96 3.51¡0.61 3.25¡0.69 0.605
p-value 0.911 0.506 0.011
SDL (palm to wrist) Baseline 2.76¡0.55 2.75¡0.55 2.79¡0.60 0.318
Post-treatment 2.76¡0.72 2.65¡0.62 2.84¡0.57 0.912
p-value 1.00 0.042 0.336
Distal motor latency Baseline 4.17¡0.70 4.20¡0.90 4.60¡1.23 0.403
Post-treatment 4.19¡0.82 4.17¡0.086 4.45¡1.37 0.714
p-value 0.889 0.725 0.271
SNCV(digit II to palm) Baseline 32.74¡5.29 33.13¡4.79 32.26¡7.51 0.922
Post-treatment 33.76¡6.75 32.53¡4.61 33.32¡7.74 0.866
p-value 0.214 0.479 0.101
SNCV (palm to wrist) Baseline 25.46¡6.75 26.28¡4.17 27.04¡5.65 0.743
Post treatment 26.82¡6.25 29.66¡6.09 32.03¡6.84 0.094
p-value 0.203 0.008 0.003
SNCV: Sensory nerve conduction velocity.
SDL: Sensory distal latency.
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US is assumed to be an anti-inflammatory procedure
that increases blood flow, local metabolism and tissue
regeneration in target tissues in addition to reducing edema
and pain and limiting nerve compression (1).
Evidence of an anti-inflammatory effect of US treatment
from experiments on the stimulation of nerve regeneration
and on nerve conduction supports the idea that US
treatment may facilitate recovery from nerve compression
(27-30).
In our study, the patients that were treated with pulsed
and continuous US showed electrophysiological improve-
ment; however, these results were not superior to those
that were observed with the placebo. We believe that this
electrophysiological improvement is related to the mechan-
ism of action of the US therapy. Further, the lack of
intergroup differences in the electrophysiological para-
meters may be related to the small sample size.
There are no studies currently available comparing the
effects of continuous and pulsed US. The relatively small
number of patients and lack of data describing a long-term
follow-up of the patients were the main limitations of our
study.
In our study, splinting therapy in combination with
pulsed or continuous US or placebo showed similar clinical
results. Patients who were treated with continuous and
pulsed US showed electrophysiological improvement; how-
ever, the results that were obtained, were not superior to
those that were reported with the placebo. There is still no
existing consensus on optimal therapeutic US parameters
and well-designed studies with long-term follow-up are
needed.
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